Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Therapy-Related Diarrhea × crofelemer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Cancer Therapy-Related Diarrhea 1 Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04538625 2024-07-26

OnTARGET

Napo Pharmaceuticals, Inc.

Phase 3 Completed

Other solid neoplasm

Cancer Therapy-Related Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡